Intellectual Property India Publishes Patent Application for 'Pharmacokinetically Engineered Diffusion Controlled Short Contact Multi-Pathway Retinoid Delivery System For Enhanced Early Dermal Flux' Filed by Skinidenticals And Innovations Private Limited

MUMBAI, India, April 17 -- Intellectual Property India has published a patent application (202641043042 A) filed by Skinidenticals And Innovations Private Limited, Hyderabad, Telangana, on April 3, for 'pharmacokinetically engineered diffusion controlled short contact multi-pathway retinoid delivery system for enhanced early dermal flux.'

Inventor(s) include Dr. Niharika Kadiyala.

The application for the patent was published on April 17, under issue no. 16/2026.

According to the abstract released by the Intellectual Property India: "Pharmacokinetically Engineered Diffusion Controlled Short Contact Multi-Pathway Retinoid Delivery System for Enhanced Early Dermal Flux [00108] The present invention relates to a short-contact topical retinoi...